Upcoming Webinars

Please note: the webinars listed on this page are hosted by other organizations, so any questions regarding the webinars should be sent to the relevant organization, and not PICNet. Webber Teleclasses are listed on a different page.

Outbreaks in Outpatient Oncology Settings: Lessons Learned and Key Considerations for Handling Sterile Medications

Host: US Centers for Disease Control and Prevention
Date: Thursday August 9, 2018
Time: 9am PDT
Register here

Topics: This webinar will discuss infectious outbreaks in outpatient oncology settings that have been linked to breaches in safe injection practices and sterile compounding standards. We will also discuss key considerations for safe handling of sterile medications during compounding and administration.


  • Identify unsafe injection and compounding practices that have been linked to healthcare-associated infection (HAI) outbreaks in outpatient oncology and other clinic settings
  • Identify the minimum standards for safe injection practices and when standards for sterile compounding are applicable.

Describe the importance of early recognition and notification of potential HAI outbreaks to public health authorities.

Featured Speakers: Nadine Shehab, PharmD, MPH, senior scientist, Division of Healthcare Quality Promotion, CDC
Joseph Coyne, RPh, director of field operations, Clinical IQ
Martha Polovich, PhD, RN, AOCN, assistant professor, College of Nursing and Health Professions, Georgia State University
Lisa Richardson, MD, MPH, director, Division of Cancer Prevention and Control, CDC

Recently Archived Webinars

BCCDC Grand Rounds: Cytokines and signaling molecules predict clinical outcomes after severe infection in sepsis patients

Click here for details

Presenter: Dr. Chris Fjell
Click here for archived webinar

Speaker bio: Chris Fjell, PhD, is a clinical genomic microbiologist at the Public Health Lab of the BC CDC. Prior to starting at the BC CDC last month, Chris studied pathogen and host response in critical care medicine at St Paul’s hospital (Centre for Heart Lung Innovation, UBC) and UBC department of Microbiology & Immunology, was a staff health data analyst at Vancouver Coastal Health Research Institute (UBC), and staff scientist at the BC Cancer Agency Centre for Clinical Genomics.

Abstract: Sepsis is a life-threatening syndrome following severe infection due to immune response; organ failure occurs despite absence of infection at sites of failing organs. The immune response during sepsis is incompletely understood due to small sample sizes and variable timing of measurements following the onset of symptoms. The vasopressin in septic shock trial (VASST) compared the addition of vasopressin to norepinephrine alone in patients with septic shock. During this study plasma was collected and 39 cytokines measured in a 363 patients at both baseline (before treatment) and 24 hours. Clinical features relating to both underlying health and the acute organ dysfunction induced by the severe infection were collected during the first 28 days of admission. Cluster analysis of cytokines identifies three subgroups of patients at differing risk of death and organ failure; however, these subgroups do not correspond to the infecting pathogen. Depending on the level of immune response as identified by cytokine concentrations, vasopressin offers benefit over norepinephrine alone.

BCCDC Grand Rounds: Bioinformatics activities for genomic sequencing in the Public Health Lab

Click here for details

Date and time: Tuesday, May 1, 12-1 pm
Presenter: Dr. William Hsiao
Click here for archived webinar

Speaker bio: Dr. William Hsiao joined BCCDC Public Health Laboratory in September 2011 as the Lead Bioinformatician. He has established the bioinformatics analysis platforms and services in the PH Lab in the last few years, while conducting research as a Clinical Assistant Professor in the department of Pathology and Laboratory Medicine at UBC. In 2017, he moved into a Senior Scientist position co-funded by the BC Ministry of Agriculture and supports the bioinformatics analysis of both PHL and Animal Health Centre. His current research focuses on developing bioinformatics applications, and using next generation sequencing technologies to study microbial pathogens and microbial communities (microbiomes). He has participated in several genomics and metagenomics projects and is currently leading the effort to develop a bioinformatics platform to use whole genome sequencing to facilitate public health infectious disease outbreak investigations. The other half of his group works on knowledge integration using “ontology” – another topic for another day. Overall, his research aims to improve our understanding of the pathogens that make us sick and the microbiota that keep us healthy.

High throughput sequencing technologies have provided transformative tools for infectious disease surveillance and outbreak investigations. Many research studies have shown the effectiveness of using genomic fingerprinting for tracking transmission and for identifying sources of infection. Yet, the amount of data generated by these sequencers and the complexity of sample and data analytical workflows means routine use of these technologies is still challenging. In this talk, I will discuss some of the software tools and platforms that we have setup at the public health lab to facilitate genomic analysis and to invite others who are interested in our service to discuss their needs with us.

BCCDC Grand Rounds: Options for treating latent TB infection

Click here for details

Presenter: Dr. Victoria Cook
Date and time: Tuesday, April 17, 2018  
Webinar link: Click here to view the archived webinar

Talk Summary/Learning objectives:

  1. Understand the use and limitations of Isoniazid to treat LTBI
  2. Explore “new” options to treat LTBI
  3. Appreciate the programmatic roll-out of LTBI treatment

Speaker bio: Dr. Victoria J Cook has been based at the BC Centre for Disease Control, Division of TB Control since 2002. Dr. Cook is a member of the Respiratory Division at Vancouver General Hospital, is a Clinical Associate Professor in the Faculty of Medicine at UBC, and is the current Training Program Director for UBC Adult Respirology. As physician consultant for the on-reserve TB program (TBSAC), she became particularly interested in the implementation and evaluation of novel strategies to control tuberculosis (TB) in high-risk populations. Ongoing research includes exploring ways to improve LTBI diagnosis and treatment completion in persons at risk for TB. Currently, she is the Medical Head of Provincial TB Services. She provides consultative services to the First Nations Health Authority and the Yukon Government. She continues to provide clinical care in the Provincial TB Clinics and on the TB Ward at VGH. She also supports TB programming across the province and nationally working with partners in the Regional Health Authorities and federal agencies. Dr. Cook is the co-chair of the BC TB Strategic Committee, working to implement the Provincial Strategic Plan for TB Prevention, Treatment and Control. She is also the current President of the North American Region of The Union (International Union against TB and Lung Diseases).

March 27

BCCDC Grand Rounds: The Ethics of Antibiotic Stewardship – What is Stewardship and Who is a Steward?

Click here for details

Hosted by: BCCDC
Presenter: Dr. Adrian M. Viens
Date and time: Tuesday, March 27, 2018  12:00 PM PDT
Webinar link

Bio of the speaker: Dr. A.M. Viens is an Associate Professor in Public Health Law at the University of Southampton. He is also Director of the Centre for Health, Ethics and Law (HEAL) and the Public Health Ethics and Law Research Group (PHEL).  His research centres on issues at the intersection of moral, political and legal theory and public policy, with a particular focus on how human behaviour, social conditions and regulation impact health. His current research examines different issues within public health and global health policy, practice and research (especially in relation to communicable disease control, antimicrobial resistance and public health emergencies). He sits on the Health Protection Committee and the Ethics Committee at the UK Faculty of Public Health. He is on the editorial boards of Public Health Ethics, Bioethics and Health Care Analysis, and is also a fellow of the Royal Society of Public Health.

Summary of the talk: With greater awareness of the emergence and spread of antibiotic resistance and the seriousness of its consequences, there has been a concerted push towards antibiotic stewardship. The almost exclusive focus of these stewardship activities, however, has concerned medical and scientific matters. While stewardship certainly involves decision-making and policy-making concerning these technical matters, stewardship also involves decision-making and policy-making concerning matters that are inherently and inescapably ethical. Acting as a steward will often involve making moral judgments, promoting particular values and prioritizing different aims – which are normative, and not technical, activities. This paper will argue we should understand antibiotic stewardship as a normative enterprise (involving the need to clarify how we should understand the concept of stewardship and its values) and the need to understand stewardship as a form of governance. This can help us to better clarify and justify how we should understand the role and responsibilities of antimicrobial stewards. 

Canadian Sentinel Practitioner Surveillance Network (SPSN) first estimates of mid-season influenza vaccine effectiveness (VE) for the 2017/18 season

Click here for details

Host: BCCDC Grand Rounds
Date and time:
Tuesday Feb 27, 12-1 pm   
Webinar link: click here 
Please note:  you will need MS Silverlight to view this webinar.  According to PHSA Mediasite, Google Chrome no longer supports the Microsoft Silverlight player that is required for these live webcasts. If you have a PC, then Internet Explorer should work. If you are using a Mac, we recommend using Firefox.

Presenter: Dr. Danuta Skowronski

Topic: The 2017/18 influenza season has been characterized by co-circulation of A (H3N2) and B (Yamagata) viruses, the latter unusual so early in the season. Low vaccine effectiveness (VE) was anticipated following interim report from Australia indicating VE of just 10% using the same vaccine components during its 2017 A(H3N2) epidemic. Dr. Skowronski will present interim 2017/18 VE estimates from participating provinces of the Canadian Sentinel Practitioner Surveillance Network (SPSN), alongside genetic characterization of contributing viruses.

Presenter Bio: Dr. Danuta Skowronski is Epidemiology Lead responsible for surveillance, rapid response research and program/policy recommendations for Influenza and Emerging Respiratory Pathogens at the BC Centre for Disease Control (BCCDC). She has ~145 scientific publications, primarily related to influenza, and has participated in numerous provincial, national and international expert advisory committees and guidelines. 

BCCDC Grand Rounds: Canadian National Vaccine Safety (CANVAS) Network: Active Safety Surveillance for Influenza Vaccines, 2017-18

Click here for details

Host: BCCDC Grand Rounds
Date and time:
February 6
: Lane Level Lecture Hall
Webinar link: click here

Presenter: Dr. Julie Bettinger

Summary of the talk: The Canadian National Vaccine Safety (CANVAS) network, a sentinel network, was established in 2009 and now provides annual influenza vaccine safety information from >35,000 adults and children across Canada. The primary objective is to estimate the frequency of adverse events of sufficient severity to cause medical consultation or prevent daily activities in children and adults vaccinated against influenza and to determine whether event rates in vaccinees are higher than event rates in unvaccinated controls. Safety data from this season’s influenza vaccines will be discussed.

Bio: Dr. Bettinger is an Associate Professor at the Vaccine Evaluation Center in the Department of Pediatrics at the University of British Columbia and a Michael Smith Foundation for Health Research Scholar. She is an infectious disease epidemiologist whose research interests include vaccine safety and vaccine preventable diseases, as well as attitudes and beliefs around immunization uptake and use. She is the epidemiologist for the Canadian Immunization Monitoring Program, Active (IMPACT), an active surveillance network for vaccine preventable diseases and vaccine adverse events in 12 tertiary care pediatric hospitals across Canada and the lead investigator for CIRN’s Canadian National Vaccine Safety (CANVAS) network, which monitors the safety of influenza vaccines each year.

BCCDC Grand Rounds: Salmonella Enteritidis: Can Whole Genome Sequencing Tackle This Elusive Enteric Pathogen?

Click here for details

Host: BCCDC Grand Rounds
Date and time:
  January 30, 12-1pm 
Webinar link: click here.

Presenters: Drs. Linda Hoang and Natalie Prystajecky

Summary of the talk: Salmonella Enteritidis (SE) continues to be one of the most prevalent bacterial enteric pathogens in BC (MT: consider adding a comment that it has been causing an outbreak in BC since 2008). Laboratory-based surveillance using typing tools such as Pulsed Field Gel Electrophoresis (PFGE) and Phage Typing (PT) have not provided sufficient discriminatory power to identify clusters for public health follow up. Since May 2017, whole genome sequencing (WGS) methods are routinely used for laboratory-based surveillance of human Salmonella in BC and Canada. In addition to highlighting the utility of WGS methods for enteric outbreak investigations, we will present preliminary SE One Health perspective, integrating clinical, animal and food data to show the relationship between SE strains found in human, animal and food and improving our understanding of the sources of human illness.


Dr. Linda Hoang is a Medical Microbiologist based at the BC Centre for Disease Control as the Program Head for Bacteriology & Mycology laboratory since 2006. Her clinical and academic interests include healthcare-acquired infections and antibiotic resistant organisms, agents of bioterrorism and containment level-3 pathogens, and enteric bacterial pathogens related outbreaks in BC.

Dr. Natalie Prystajecky is the Program Head for Environmental Microbiology at the BCCDC Public Health Laboratory and Clinical Assistant Professor at UBC. Her work at the BCCDC PHL is at the intersect of environmental exposures (food and water) and clinical outcomes, and using emerging technologies to improve surveillance and outbreak investigations. Her research interests are broad, ranging from water metagenomics, to targeted resequencing of wetland sediments for avian influenza to whole genome sequencing of Salmonella.

About the Grand Rounds: BCCDC Public Health Grand Rounds is a self-approved group learning activity as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.  Offsite participants (MDs only) can earn MoC credits by notifying Cletus.DSouza@bccdc.ca  about their attendance providing their name, title, institution, email address and phone. 

BCCDC Grand Rounds: Solutions to the Problem of Infections Caused by Multi-Drug (MDR) Resistant Infections

Click here for details

Host: BCCDC Grand Rounds
 January 23  
Webinar link: click here 
Please note:  you will need MS Silverlight to view this webinar.  According to PHSA Mediasite, Google Chrome no longer supports the Microsoft Silverlight player that is required for these live webcasts. If you have a PC, then Internet Explorer should work. If you are using a Mac, we recommend using Firefox.

Presenter: Dr. George Zhanel

Summary of the talk: Dr. Zhanel will talk about: infection control, antibiotic stewardship, new and investigational, bacteriotherapy and the SAVE vaccine study. Objectives for this talk include:
1. review the key pathogens of interest causing antimicrobial resistant infections
2. discuss the role of infection control and antimicrobial stewardship in controlling resistant infections
3. review new/investigational antibiotics
4. Discuss the roe of vaccination to lower resistance infections.

Bio: Dr. Zhanel received his Ph.D. in the Department of Medical Microbiology/Infectious Diseases at the Faculty of Medicine, University of Manitoba and a Doctor of Clinical Pharmacology at the University of Minnesota. He is presently Professor in the Department of Medical Microbiology/Infectious Diseases, College of Medicine; Course Leader, Infectious Diseases Teaching, College of Medicine, University of Manitoba; Coordinator of Antibiotic Resistance in the Departments of Medicine and Clinical Microbiology, Health Sciences Centre; and Research Director of the Canadian Antimicrobial Resistance Alliance (CARA). Dr Zhanel is the founding and Chief Editor of the Canadian Antimicrobial Resistance Alliance (CARA) website (www.can-r.ca). As research director of the Canadian Antimicrobial Resistance Alliance, Dr. Zhanel’s research interests include understanding the prevalence, epidemiology and spread of antimicrobial resistant infections, describing the clinical relevance of resistant infections, identifying and developing rapid diagnostic methods to rapidly diagnose infections, investigating the cellular and molecular mechanisms of resistance, assessing activity of investigational antimicrobials as well as discovering novel antimicrobials (holder of several patents). Dr. Zhanel has been involved in treatment guideline development for a variety of infectious diseases and is also interested in antimicrobial usage/resistance in humans, animals and food and the impact of antimicrobial exposure on human and animal microbiomes. 

Reducing infection rates through optimal healthcare design: How you can change your environment to positively impact patient safety outcomes

Click here for details

Host: CPSI
Date:  January 23 
Read more and view the archive here 

Presenters: Tracey Herlihey PhD, Chantal Trudel MSc, and Janet Brintnell

Webinar summary: Think Human factors doesn’t have an impact on clinical outcomes like infection rates? Guess again! According to the World Health Organization (2017), infections acquired in healthcare settings represent the most frequent adverse event occurring in the delivery of healthcare and no institution or country has solved the problem yet. Furthermore, with growing concerns for antibiotic resistance, effective strategies to support infection prevention and control (IPAC) are in desperate need.

This webinar presents two case studies where human factors/ergonomics research and interventions focused on improving our understanding of design’s influence on infection transmission and design considerations to support IPAC. These case studies will help organizations see the benefits of applying a human factors approach in designing optimal environments to reduce the spread of infection.

Vector-borne and Zoonotic Diseases in BC: Using Cases to Understand Diagnostic and Public Health Challenges

Click here for details

Host: BCCDC Grand Rounds
Date and time:
January 9, 12-1pm
Webinar link: click here

Presenter: Dr. Muhammad Morshed

Bio: Dr. Muhammad Morshed is a Clinical Microbiologist and Program Head of Zoonotic Diseases and Emerging Pathogens Section as well as Parasitology Section of BC Centre for Disease Control’s Public Health Laboratory. He is also a Clinical Professor in the Department of Pathology & Laboratory Medicine, Faculty of Medicine, at University of British Columbia. His laboratory is responsible for specialized serology testing, molecular testing and microbial fingerprinting, program evaluation on various vector-borne, zoonotic diseases and emerging pathogens. His research interest primarily focused on syphilis and Lyme disease.

Influenza, 2017-18: Issues and Implications

Click here for details

Host: BCCDC Grand Rounds
Date and time:
Dec 5th 2017, 12:00- 1:00PM   
Presenter: Dr. Danuta Skowronski
Webinar link: click here 

Topic: Amid much speculation, join us to hear this influenza expert provide a candid analysis of issues and implications for the upcoming influenza season.

Presenter Bio: Dr. Danuta Skowronski is Epidemiology Lead responsible for surveillance, rapid response research and program/policy recommendations for Influenza and Emerging Respiratory Pathogens at the BC Centre for Disease Control (BCCDC). She has ~145 scientific publications, primarily related to influenza, and has participated in numerous provincial, national and international expert advisory committees and guidelines.

BCCDC Grand Rounds Archives

Did you miss a Grand Round that you’d like to have seen? Most of them are archived on the PHSA Mediasite.

BC Patient Safety and Quality Council (BCPSQC) Webinars

There are many archived webinars on the BCPSQC website.